KFAS
AVNS

Keating Financial Advisory Services’s Avanos Medical AVNS Stock Holding History

Keating Financial Advisory Services’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518 Buy
37
+20
+118% +$269 ﹤0.01% 2256
2025
Q4 		$191 Buy
+17
New +$195 ﹤0.01% 2079

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Keating Financial Advisory Services's AVNS Position: Q1 2026 in Review

Keating Financial Advisory Services increased its Avanos Medical (AVNS) stake by 118% in Q1 2026, buying an estimated $269 and bringing the position to 37 shares worth $518. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Keating Financial Advisory Services first reported a position in AVNS in Q4 2025 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Keating Financial Advisory Services held 37 shares of Avanos Medical worth $518 as of Q1 2026.
  • Keating Financial Advisory Services bought 20 Avanos Medical shares in Q1 2026, an estimated $269.
  • Avanos Medical made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q1 2026, its #2256 holding.
  • Keating Financial Advisory Services first reported a position in Avanos Medical in Q4 2025 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.